Continuous Peripheral Nerve Block Catheter Market – Insights
A continuous peripheral nerve block catheter (CPNBC) is inserted with its tip adjacent to a target nerve/plexus through, which local anesthetic may be administered. Nerve blocks for hand surgery usually last for 6-8 hours, whereas a nerve block for pain after total knee replacement can last for 12-24 hours.
Global Continuous Peripheral Nerve Block Catheter Market: Drivers
Increasing incidence of trauma and accidental injuries is expected to propel growth of the global continuous peripheral nerve block catheter market over the forecast period. For instance, according to January 2018 factsheet, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S.
Moreover, increasing preference for nerve block technique for pain management as opposed to opioids is also expected to aid in growth of the market. Use of opioids for pain management is associated with several adverse effects such as addiction, sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance, and respiratory depression.
North America region held dominant position in the global continuous peripheral nerve block market in 2019, accounting for 42.9% share in terms of value, followed by Europe.
Figure 1. Global Continuous Peripheral Nerve Block Catheter Market Share (%), by Region, 2019
Global Continuous Peripheral Nerve Block Catheter Market: Restraints
Complications associated with CPNBC are expected to hinder growth of the market. Severe complications of using CPNBC include peripheral nerve injury and catheter infection associated with continuous peripheral nerve block catheters dissuades anesthesiologist to a certain extent.
Moreover, lack of standard usage guidelines and trained personnel is also expected to aid in growth of the market. Usage of continuous peripheral nerve block catheter is not uniform and proper documentation for usage and proper guidance for local anesthesia and analgesics intake is not widely available. Placement of CPNBC requires high monitoring under the guidance of skilled professionals.
Global Continuous Peripheral Nerve Block Catheter Market: Opportunities
Lower opioid usage for post-operative pain management is expected to offer lucrative growth opportunities for players in the global continuous peripheral nerve block market. For instance, according to the U.S. Department of Health and Human Services, during January 2017 and February 2019, the total amount of opioid prescription decreased by 34% in the U.S.
Moreover, significant number of prospective studies are required to confirm the efficacy and safety of CPNBC. Existing studies have several restrictions and it is difficult to compare studies as there are differences in the definition of side effects caused due to CPNBC.
Stimulating Catheter segment in the global Continuous Peripheral Nerve Block Catheter market was valued at US$ 142.7 Mn in 2019 and is expected to reach US$ 228.1 Mn by 2027 at a CAGR of 6.0% during the forecast period.
Market Trends/Key Takeaways
The adoption of acute pain management after major surgeries has gained preference, which is increasing the demand for CPNBC in hospitals and home settings. Low cost of CPNBC is also increasing their adoption.
The use of bupivacaine to reduce pain and opioid use has increased. For instance, in June 2019, Pacira Biosciences, Inc. released data from its Phase 3 study, which examined the efficacy and safety of EXPAREL (bupivacaine liposome injectable suspension) as a single-injection interscalene brachial plexus nerve block in patients undergoing total shoulder arthroplasty or rotator cuff repair.
Global Continuous Peripheral Nerve Block Catheter Market: Competitive Landscape
Major players operating in the global continuous peripheral nerve block catheter market include, B. Braun Melsungen AG, Halyard Health, Inc., Ambu A/S, Epimed International Inc., Teleflex Incorporated, and Pajunk GmbH
Global Continuous Peripheral Nerve Block Catheter Market: Key Developments
Major players in the market are focused on launching new products to expand their product portfolio. For instance, in April 2018, Smiths Medical announced to introduce EchoGlo peripheral nerve block (pnb) needles and catheters that are visible under ultrasound at any angle or orientation.